4.7 Article

miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer

Related references

Note: Only part of the references are listed.
Review Oncology

Constitutive activation of STAT3 in breast cancer cells: A review

Kasturi Banerjee et al.

INTERNATIONAL JOURNAL OF CANCER (2016)

Article Biochemistry & Molecular Biology

OncomiR miR-96 and miR-182 Promote Cell Proliferation and Invasion Through Targeting EphrinA5 in Hepatocellular Carcinoma

Tong-Hong Wang et al.

MOLECULAR CARCINOGENESIS (2016)

Article Medical Laboratory Technology

Tumor MicroRNA Expression Profiling Identifies Circulating MicroRNAs for Early Breast Cancer Detection

Nerea Matamala et al.

CLINICAL CHEMISTRY (2015)

Article Oncology

MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7

Xiaoying Zhou et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)

Review Chemistry, Multidisciplinary

Protein tyrosine phosphatases as potential therapeutic targets

Rong-jun He et al.

ACTA PHARMACOLOGICA SINICA (2014)

Article Biochemistry & Molecular Biology

CDK inhibitors, p21Cip1 and p27Kip1, participate in cell cycle exit of mammalian cardiomyocytes

Shoji Tane et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)

Article Medicine, Research & Experimental

MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer

Haifeng Xia et al.

BIOMEDICINE & PHARMACOTHERAPY (2014)

Article Cell Biology

miR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells

Haizhou Guo et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)

Article Oncology

miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer

Yan Guo et al.

ONCOLOGY LETTERS (2012)

Article Biochemistry & Molecular Biology

Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21

Yuefeng Wang et al.

NATURE CHEMICAL BIOLOGY (2011)

Article Biochemistry & Molecular Biology

Protein-tyrosine Phosphatase PTPN9 Negatively Regulates ErbB2 and Epidermal Growth Factor Receptor Signaling in Breast Cancer Cells

Taichang Yuan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Biotechnology & Applied Microbiology

Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

Li Ma et al.

NATURE BIOTECHNOLOGY (2010)

Article Multidisciplinary Sciences

miR-221 overexpression contributes to liver tumorigenesis

Pascal Pineau et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Biochemistry & Molecular Biology

Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model

Janaiah Kota et al.

Article Biochemistry & Molecular Biology

Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells

Irene K. Guttilla et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Review Biochemistry & Molecular Biology

MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster

Shunbin Xu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Review Cell Biology

Protein tyrosine phosphatases: from genes, to function, to disease

Nicholas K. Tonks

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)

Article Oncology

MicroRNA gene expression deregulation in human breast cancer

MV Iorio et al.

CANCER RESEARCH (2005)

Article Multidisciplinary Sciences

MicroRNA expression profiles classify human cancers

J Lu et al.

NATURE (2005)

Article Genetics & Heredity

Combinatorial microRNA target predictions

A Krek et al.

NATURE GENETICS (2005)

Review Biochemistry & Molecular Biology

Human MicroRNA targets

B John et al.

PLOS BIOLOGY (2004)

Article Biochemistry & Molecular Biology

Prediction of mammalian microRNA targets

BP Lewis et al.

Review Oncology

Transcription factors as targets for cancer therapy

JE Darnell

NATURE REVIEWS CANCER (2002)

Review Biochemistry & Molecular Biology

STAT proteins: novel molecular targets for cancer drug discovery

J Turkson et al.

ONCOGENE (2000)